pharma news today obesity drug glp-1 drugs to be new growth engine for industry: Sun Pharma | Company 🧬 Could this be the

Appl Microbiol Biotechnol 106(23):79177931 Liu L et al (2022) Functional comparison of Clostridium butyricum and sodium butyrate supplementation on growth, intestinal health, and the anti-inflammatory response of broilers

Its related to how these medications affect appetite regulation and metabolism

#GLP1 #Semaglutide #Pharma #Healthcare #India #DrugPricing #PatientAccess Cyril Amarchand Mangaldas Priyan Garg To view or add a comment, sign in A new challenger in the oral GLP-1 race The landscape for oral weight loss drugs is shifting

Male-specific tirzepatide outcomes and weight loss strategies for women offer gender-specific context

it means the dose-response, long-term safety, and population-level risk profile of Melanotan II in humans are fundamentally unknown